期刊文献+

卵巢上皮性肿瘤中含激酶结构域新原癌基因和磷酸化信号转导及转录活化因子3的表达及意义 被引量:4

Expressions of Novel Oncogene with Kinase-Domain and Phospho-Signal Transducer and Activator of Transcription 3 in Ovarian Cancer and the Significances
下载PDF
导出
摘要 目的探讨含激酶结构域新原癌基因(NOK)和磷酸化信号转导及转录活化因子3(p-STAT3)在卵巢上皮性肿瘤中的表达及意义。方法采用免疫组化SP法检测40例恶性卵巢上皮性肿瘤组织(恶性组)、30例良性卵巢上皮性肿瘤组织(良性组)和20例正常卵巢组织(正常组)中NOK和p-STAT3的表达。结果NOK在恶性组阳性表达率与良性组和正常组比较,差异有统计学意义(P<0.05);恶性组p-STAT3的阳性表达率与良性组和正常组比较,差异有统计学意义(P<0.05)。恶性组NOK的表达与患者年龄、淋巴转移、病理类型、临床分期和病理分级均无统计学意义(P>0.05),而p-STAT3的表达,在不同临床分期、病理分级和有无淋巴转移间差异均有统计学意义(P<0.05)。在恶性卵巢肿瘤组织中NOK与p-STAT3表达呈正相关(r=0.575,P<0.05)。结论NOK在恶性卵巢肿瘤的表达量较高,p-STAT3的异常活化可促进恶性卵巢肿瘤细胞的过度增殖,两者结合检测对恶性卵巢肿瘤的早期临床诊断和治疗可能有一定价值。 Objective To investigate the expressions of novel oncogene with kinase-domain (NOK) and phospho-signal transducer and activator of transcription 3 (p-STAT3) in the epithelial ovarian cancer and their significances.Methods The expressions of NOK and p-STAT3 were examined by immunohistochemistry-streptavdin-peroxidase method in epithelial tissues of malignant ovarian tumor (malignant group,n=40),benign ovarian tumor (benign group,n=30),and normal ovary (normal group,n=20).Results The positivity rate of NOK expression was significantly higher in the malignant group than in the benign and normal groups (P〈0.05).The positivity rate of p-STAT3 expression in ovarian cancer was significantly higher in the malignant group than in the benign and normal groups (P〈0.05).The NOK expression was not significantly associated with patient's age,lymphatic metastasis,histological types,clinical stage and histological grade (P〉0.05),but the p-STAT3 expression was significantly associated with lymphatic metastasis,histological grade and clinical stage (P〈0.05).The NOK expression was positively correlated with p-STAT3 expression (r=0.575 P〈0.05).Conclusion The expression of NOK is higher in epithelial ovarian cancer.Abnormal activation of STAT3 may cause hyper-proliferation of ovarian tumor cells.To detect NOK and p-STAT3 in combination may have a certain value for an early diagnosis and management of ovarian caner.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第12期1301-1303,共3页 Chinese General Practice
关键词 卵巢上皮性肿瘤 含激酶结构域新原癌基因 磷酸化信号转导及转录活化因子3 细胞增殖 Epithelial ovarian tumor Novel oncogene with kinase-domain Phospho-signal transducer and activator of transcription 3 Cell proliferate
  • 相关文献

参考文献15

  • 1Heintz AP,Odicino F,Maisonneuve P,et al.Carcinoma of the ovary[J].Int J Gynaecol Obstet,2003,83(10):135-166.
  • 2Hartmann JT,Haap M,Kopp HG,et al.Tyrosine kinase inhibitors a review on pharmacology,metabolism and side effects[J].Curr Drug Metab,2009,10(5):470-481.
  • 3Schmandt RE,Broaddus R,Lu KH,et al.Expression of c-ABL,c-KIT,and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium[J].Cancer,2003,98(4):758-764.
  • 4Bromberg JF,Wreszczynska MH,Devgan G,et al.STAT3 as an oncogene[J].Cell,1999,98:295-303.
  • 5Mizoguchi M,Betensky RA,Batchelor TT,et al.Activation of STAT3,MAPK,and AKT in malignant astrocytic gliomas:correlation with EGFR status,tumor grade,and survival[J].Neuropathol Exp Neurol,2006,65:1181-1188.
  • 6Liu L,Yu XZ,Li TS,et al.A novel protein tyrosine kinase NOK that shares homology with platelet-derived growth factor/fibroblast growth factor receptors induces tumorigenesis and metastasis in nude mice[J].Cancer Res,2004,64(10):3491-3499.
  • 7Amachka T,Kobayashi D,Moriai R,et al.Diagnostic relevance of over-expressed mRNA of novel oncogene with kinase-domain (NOK)in lung cancers[J].Lung Cancer,2007,56(3):337-340.
  • 8Kimbro KS,Duschene K,Willard M,et al.A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment[J].Mol Biol Rep,2008,35(1):23-27.
  • 9Levy DE,Darnell JEJr.Stats:transcriptional control and biological impact[J].Nat Rev Mol Cell Biol,2002,3:651-662.
  • 10Niu G,Wright K L,Hung M,et al.Constitutive STAT3 activity up-regulates VEGF expression and tumor angiogenesis[J].Oncogene,2002,21(13):2000.

同被引文献24

  • 1徐海耿,王华.p53蛋白在上皮性卵巢癌的表达及临床意义[J].中国临床医学,2005,12(3):489-490. 被引量:5
  • 2张兴泰.下肢骨肉瘤术后存活17年1例报告[J].西部医学,2005,17(6):619-619. 被引量:1
  • 3De Arafijo WM,Vidal FC, De Souza WF, et al. PI3K/ Akt and GSK-3β prevents in a differential fashion the malignant phenotype of eoloreetal eaneer cells[J]. J Cancer Res Clin Oneol,2010, 136(11): 1773-1782.
  • 4Moore DD, Luu HH. Osteosarcoma I-J]. Cancer Treat Res, 2014, 162.65-92.
  • 5Yu H, Lee H, Herrmann A, etal. Revisiting STAT3 signalling in cancer: new and unexpected biological functions [J]. Nat Rev Cancer, 2014, 14(11) :736-746.
  • 6Wang SW, Sun YM. The IL-6/JAK/STAT3 pathway: poten- tial therapeutie strategies in treating coloreetal cancer (Review) [J]. IntJOneol, 2014, 44(4) :1032-1040.
  • 7Zhu T, Wang DX, Zhang W, etal. Andrographolide protects a- gainst LPS-induced acute lung injury by inactivation of NF-~B I-J]. PLoS One, 2013, 8(2):e56407.
  • 8Ma X, Chen R, Liu X, et al. Effects of matrine on JAK-STAT signaling transduction pathways in bleomycin-induced pulmonary fibrosis [-J]. Afr J Tradit Complement Altern Med, Z013, 10 (3) :442-448.
  • 9Tu B, Du L, Fan QM, et al. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metasta- sis of osteosarcoma l-J]. Cancer Lett, 2012, 325(1):80-88.
  • 10Wang X, Goldstein D, Crowe PJ, etal. Impact of STAT3 inhi- bition on survival of osteosarcoma cell lines l-J]. Anticancer Res, 2014, 34(11)~6537-6545.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部